Skip to main content
Caplight Logo









CyteSi, Inc.

CyteSi, Inc.

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://cytesi.com

Last Round

Series A

Extension

May 3, 2024

Total Funding Raised

$12.4M

Company Overview

CyteSi, Inc. operates in Healthcare & Life Sciences and is based in Menlo Park, California. Its latest recorded funding round was a Series A Extension round in May 2024.

CyteSi, Inc. is a biotechnology company that develops digital microfluidics systems and Biological Processing Units (BPUs) to automate and digitize life science research workflows.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery, Workflow Automation, Semiconductors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CyteSi, Inc. Comparables

Compare CyteSi, Inc. with similar companies based on industry and business-model similarity.

CyteSi, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Volta Labs
84%
Guangdong ACXEL Micro & Nano Tech Co., Ltd.
83%
INTEGRA Holding AG
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CyteSi, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMay 3, 2024
Series AJun 3, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2024

    Raised $5.5M in a Series A Extension round.

  • Jun 3, 2022

    $7M round completed.

Book a demo to see all signals

For institutional investors. Book with your work email.

CyteSi, Inc. Filings

Explore SEC and related filing metadata, where available.

CyteSi, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CyteSi, Inc.'s valuation, stock price, and market status.

Is CyteSi, Inc. a public or private company?

CyteSi, Inc. is a private company.

What is the current stock price of CyteSi, Inc.?

CyteSi, Inc. is a private company, so its shares have no public market price. Caplight tracks CyteSi, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CyteSi, Inc. worth (valuation)?

Valuation information for CyteSi, Inc. is not publicly available.

Can I buy CyteSi, Inc. stock?

CyteSi, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CyteSi, Inc.'s last funding round?

CyteSi, Inc.'s most recent funding round was Series A Extension on May 3, 2024.

Who are the main investors in CyteSi, Inc.?

Investor information for CyteSi, Inc. is not publicly disclosed.

Will CyteSi, Inc. IPO soon?

No public IPO plans have been announced for CyteSi, Inc..

How can I track CyteSi, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in CyteSi, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersMenlo Park, California
Year Founded2018
Last FundingMay 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?